Posts by: Anna Tan, RN

Anna Tan, RN

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

August 12, 2015November 9, 2015

Sequadra Inhaler (indacaterol/glycopyrronium) by Novartis Launched for COPD Maintenance

COPD, News

Novartis Healthcare Private Ltd (NHPL) has launched the Sequadra Inhaler (indacaterol/glycopyrronium) 110mcg/50mcg, a treatment for chronic obstructive pulmonary disease (COPD), which is a fixed dose combination of 2 bronchodilating compounds: indacaterol maleate, a long-acting ... Read more

August 10, 2015November 6, 2015

Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada

Asthma, News

GlaxoSmithKline (GSK) and VIBATIV® (telavancin) developer Theravance Biopharma, have just been granted Canadian approval for Breo Ellipta, a once-a-day maintenance treatment for asthma in patients who are at least 18 ... Read more

August 5, 2015August 5, 2015

Foregoing Follow-Up Appointments with Pulmonologist Ups Risk of COPD Readmission, Study Shows

News

A team of researchers at the Pulmonology Institute of Soroka and Ben-Gurion University Medical Center in Israel recently published a study that suggests the risk for hospital readmission due to COPD ... Read more

August 4, 2015November 9, 2015

Online Store “Shop LLAP” Relaunches to Commemorate Star Trek Icon and COPD Victim Leonard Nimoy

COPD, News

Beloved actor, Leonard Nimoy, known best as “Spock” on Star Trek, seized the chance to become more than a science fiction icon when he became one of the faces and ... Read more

July 30, 2015November 5, 2015

Bellerophon Adds New Cardiopulmonary Indications for INOpulse System in New Licensing Agreement

News, Pulmonary Hypertension

Clinical stage biotherapeutics company Bellerophon Therapeutics recently took steps to expand its licensing agreement with INO Therapeutics LLC, a subsidiary of Mallinckrodt plc, which allows Bellerophon to advance INOpulse as a ... Read more

July 28, 2015July 28, 2015

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma

News

Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled therapeutics, for the advancement of INV104 (zafirlukast) as ... Read more

July 24, 2015November 6, 2015

Pulmatrix Acquires Two More Patents for iSPERSE Technology For Pulmonary Disease Treatments

Asthma, News

Pulmatrix, Inc., a clinical stage biopharmaceutical company focused on developing inhaled therapies to address serious pulmonary diseases, has announced the award of 2 new patents (U.S. Patent # 8,992,983 and U.S. patent # 9,061,352) from the ... Read more

July 22, 2015November 9, 2015

FDA Approves Propeller Health Mobile Platform for GlaxoSmithKline’s Diskus DPI and Boehringer’s Respimat Inhaler

COPD, News

Propeller Health, a leading mobile platform for respiratory health management that utilizes sensors, mobile apps and services to help reduce the cost of care while improving quality of life for individuals ... Read more

July 22, 2015July 22, 2015

Therabron Therapeutics’s Phase 2a Study on Pediatric Respiratory Health Solution 50% Enrolled

Chronic Bronchitis, News

Therabron Therapeutics, Inc., a biotechnology company that specializes in providing breakthrough solutions to respiratory disease management, recently announced it has already enrolled half of the targeted number of patients in a Phase ... Read more

July 21, 2015July 21, 2015

European Commission Approves Nivolumab BMS by Bristol-Myers Squibb for NSCLC

Lung Cancer, News

Bristol-Myers Squibb Company recently announced the European Commission has granted approval of Nivolumab BMS as an effective post-chemotherapy treatment for locally advanced or metastatic squamous (SQ) non-small cell lung cancer ... Read more